Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine Upregulates P-Glycoprotein in Human Caco-2 Cells and in an Experimental Model of Colitis in the Rat via Activation of Nrf2-Dependent Mechanisms
Wanghui Jing, Yasaman Safarpour, Ting Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 2, pp. 332-340
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Solomon Habtemariam
Pharmacological Research (2020) Vol. 155, pp. 104722-104722
Closed Access | Times Cited: 242
Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites
Wanghui Jing, Sijing Dong, Xialin Luo, et al.
Pharmacological Research (2020) Vol. 164, pp. 105358-105358
Closed Access | Times Cited: 142
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism
Sijing Dong, Min Zhu, Ke Wang, et al.
Pharmacological Research (2021) Vol. 171, pp. 105767-105767
Closed Access | Times Cited: 135
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
Qingrong Li, Liting Lin, Cong Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
Jiao Peng, Tingting Zheng, Xi Li, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
The influence of alkaloids on oxidative stress and related signaling pathways
Kateřina Macáková, Rita Afonso, Luciano Saso, et al.
Free Radical Biology and Medicine (2019) Vol. 134, pp. 429-444
Closed Access | Times Cited: 103
Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis
Sage E. Foley, Christine Tuohy, Merran Dunford, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Plants in vitro propagation with its applications in food, pharmaceuticals and cosmetic industries; current scenario and future approaches
Ammarah Hasnain, Syed Atif Hasan Naqvi, Syeda Iqra Ayesha, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 68
Emerging pharmacotherapy for inflammatory bowel diseases
Hua Luo, Guiqing Cao, Chun Luo, et al.
Pharmacological Research (2022) Vol. 178, pp. 106146-106146
Closed Access | Times Cited: 67
Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis
Cailan Li, Jiahao Wang, Runfang Ma, et al.
Pharmacological Research (2021) Vol. 175, pp. 105972-105972
Closed Access | Times Cited: 57
Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway
Milad Ashrafizadeh, Hojjat Samareh Fekri, Zahra Ahmadi, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 2, pp. 1575-1585
Closed Access | Times Cited: 74
Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-EP2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis
Hansheng Yu, Shaobao Zhang, Ruiming Li, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 695, pp. 149411-149411
Closed Access | Times Cited: 17
Berberine: Potential preventive and therapeutic strategies for human colorectal cancer
Yuqian Feng, Jiamin Lu, Jin Jiang, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Closed Access | Times Cited: 8
Berbamine ameliorates DSS-induced colitis by inhibiting peptidyl-arginine deiminase 4-dependent neutrophil extracellular traps formation
Wenwen Tang, Jiaze Ma, Kaidi Chen, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176634-176634
Closed Access | Times Cited: 6
Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro
Xiaoyong Guan, Xiaoting Zheng, Chi Teng Vong, et al.
European Journal of Pharmacology (2020) Vol. 875, pp. 173031-173031
Closed Access | Times Cited: 48
A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease
Lin Yang, Hua Luo, Dechao Tan, et al.
Phytomedicine (2021) Vol. 92, pp. 153709-153709
Closed Access | Times Cited: 39
Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease
Shuo Yuan, You Li, Jiao Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders
Qiukai Lu, Yifan Fu, Heng Li
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 297-309
Closed Access | Times Cited: 25
Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer
Darinka Gjorgieva Ackova, Viktorija Maksimova, Katarina Smilkov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 850-850
Open Access | Times Cited: 16
Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
Botong Li, Yixuan Wang, Xiaolin Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114950-114950
Open Access | Times Cited: 14
Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?
Simona Pompili, Roberta Sferra, Eugenio Gaudio, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 4061-4061
Open Access | Times Cited: 36
Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies
Yuhan Yang, Chi Teng Vong, Shan Zeng, et al.
Journal of Ethnopharmacology (2020) Vol. 268, pp. 113573-113573
Closed Access | Times Cited: 33
Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties
Teruo Murakami, Erik T. Bodor, Nicholas Bodor
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 3, pp. 129-137
Closed Access | Times Cited: 13
Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals
Yang Yang, Gang Xiao, Pi Cheng, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6811-6811
Open Access | Times Cited: 12
Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease
Yaqian Feng, Mengting Pan, Ruiqiong Li, et al.
Phytomedicine (2024) Vol. 132, pp. 155812-155812
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top